Metraipolis › archive › dc_ff12ec5bb8e0

Beyond Amyloid: Systemic and Brain Frailty as Determinants of Response to Anti-Amyloid Therapy in Alzheimer's Disease-A Conceptual Review — Europe PMC PMID:42654386

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42654386
DOI
10.3390/medicina62081489
License (as archived)
solo-consultazione
Archived
2026-10-17T05:45:56.541Z
SHA-256 of the archived text
4652d15fbe40a61fe3f3421700a3963c1e24825143a1e0120df030db205ddf59
Stable URL of this page
https://metraipolis.com/documento/dc_ff12ec5bb8e0

How to cite

Beyond Amyloid: Systemic and Brain Frailty as Determinants of Response to Anti-Amyloid Therapy in Alzheimer's Disease-A Conceptual Review — Europe PMC PMID:42654386 — Europe PMC (en), https://europepmc.org/article/MED/42654386 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff12ec5bb8e0 (Metraipolis archive dc_ff12ec5bb8e0, sha256 4652d15fbe40a61fe3f3421700a3963c1e24825143a1e0120df030db205ddf59)
BibTeX
@misc{dcff12ec5bb8e0,
  title = {Beyond Amyloid: Systemic and Brain Frailty as Determinants of Response to Anti-Amyloid Therapy in Alzheimer's Disease-A Conceptual Review — Europe PMC PMID:42654386},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42654386},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff12ec5bb8e0; sha256 4652d15fbe40a61fe3f3421700a3963c1e24825143a1e0120df030db205ddf59},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42654386. Agents can read the archived copy with the MCP tool read_document.